This study aimed to develop diclofenac sodium sustained-release tablets using different matrix systems and to evaluate their physicochemical properties. Diclofenac sodium was characterized for solubility, flowability, and particle size. Solubility in water and phosphate buffer (pH 7.5) was determined by UV-Vis spectrophotometry, while flowability was assessed via angle of repose, Hausner ratio, and Carr’s index. Product X SR 75 mg tablets were analyzed as a reference for uniformity, hardness, and dissolution. Two matrix approaches were explored: a hydrophobic system (carnauba wax and cetyl alcohol) via melt granulation and a hydrophilic system (Arabic gum) via direct compression. The research results indicate that diclofenac sodium exhibited slight solubility and poor flowability. Formulations based on both hydrophobic and hydrophilic systems were developed, meeting the physical, quantitative, and dissolution criteria of the United States Pharmacopeia (USP). The formulation exhibited a drug release profile in USP pH 7.5 medium equivalent to that of the reference product, Product X SR 75. The hydrophobic matrix formulations followed zero-order release kinetics, whereas the hydrophilic matrix formulations followed the Higuchi release model and showed stability over 3 months under accelerated and long-term aging conditions. Hydrophobic matrices provided a more sustained drug release compared to hydrophilic matrices. Both systems effectively modulated drug release, indicating their potential for once-daily extended-release diclofenac formulations.
Duong TLT, Huynh DTM, Nguyen TUT, Huynh QDT, Phan TTT, Tran TT, Nguyen HV, Iskandar B, Nguyen DK. Formulation development of diclofenac sodium extended-release tablet using hydrophobic and hydrophilic matrix systems. J Appl Pharm Sci. 2025. Article in Press. http://doi.org/10.7324/JAPS.2026.253028
1. Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75(8):859–77. doi: https://doi.org/10.1007/s40265-015-0392-z
2. Wheless JW, Phelps SJ.A Clinician’s guide to oral extended-release drug delivery systems in Epilepsy. J Pediatr Pharmacol Ther. 2018;23(4):277–92. doi: https://doi.org/10.5863/1551-6776-23.4.277
3. Minh-Quan L, Tra T, Do HH, Tran L, Nguyen C, Le H, et al. Preparation of sustained release naproxen sodium loaded microcapsules from alginate and chitosan through experimental design. Pharm. Sci. Asia. 2025;51:44–54. doi: https://doi.org/10.29090/psa.2025.01.24.AB0701
4. Bruschi ML. Strategies to modify the drug release from pharmaceutical systems. Elsevier: Woodhead Publishing;pp 87–194. doi: https://doi.org/10.1016/c2014-0-02342-8
5. Nokhodchi A, Raja S, Patel P, Asare-Addo K. The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts. 2012;2(4):175–87. doi: https://doi.org/10.5681/bi.2012.027
6. Lu Y, Li M. Simultaneous rapid determination of the solubility and diffusion coefficients of a poorly water-soluble drug based on a novel UV imaging system. J Pharm Sci. 2016;105(1):131–8. doi: https://doi.org/10.1016/j.xphs.2015.11.021
7. Kovvasu S, Kunamaneni P, Shankar KR. Cyclodextrins and their application in enhancing the solubility, dissolution rate and bioavailability. Innoriginal: Int J Sci. 2018;5:25–34.
8. Shah RB, Tawakkul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech. 2008;9(1):250–8. doi: https://doi.org/10.1208/s12249-008-9046-8
9. Edavalath S, Shan M. Formulation development and optimization of Diclofenac sodium extended release Matrix tablets as per USP standards. Ars Pharm. 2012;53(1):5–10.
10. Tuyen NH, Duyen HTM, Thu NTA, Trinh NTK, Phi NC, Yen TPH, et al. Application of solid dispersion technique in the formulation of Gemfibrozil 600 mg Film-coated Tablets. VNU J Sci Med Pharm Sci. 2025;41(2):15–29. doi: https://doi.org/10.25073/2588-1132/vnumps.4726
11. Nagaich U, Bharti C, Pal AK, Gulati N. Diclofenac sodium loaded sustained release matrix tablet possessing natural and synthetic polymers: Formulation and in vitro characterization. Indian J Pharm Edu Res. 2014;48:49–55. doi: https://doi.org/0.5530/ijper.48.4s.7
12. Organization WH. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. WHO technical report series. 2018. p. 953.
13. Žilnik LF, Jazbinšek A, Hvala A, Vre?er F, Klamt A. Solubility of sodium diclofenac in different solvents. Fluid Phase Equilibria. 2007;261(1-2):140–5. doi: https://doi.org/10.1016/j.fluid.2007.07.020
14. Wise DL. Handbook of pharmaceutical controlled release technology. Boca Raton, FL: CRC press; 2000.
15. Remington JP. Remington: the science and practice of pharmacy. Philadelphia, P: Lippincott Williams & Wilkins; 2006.
16. Almutairy BK, Khafagy ES, Alalaiwe A, Aldawsari MF, Alshahrani SM, Alsulays BB, et al. Enhancing the poor flow and tableting problems of high drug-loading formulation of canagliflozin using continuous green granulation process and design-of-experiment approach. Pharmaceuticals. 2020;13(12):473. doi: https://doi.org/10.3390/ph13120473
17. Alyami H, Dahmash E, Bowen J, Mohammed AR. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug. PLoS One. 2017;12(6):e0178772. doi: https://doi.org/10.1371/journal.pone.0178772
18. Kalman H. Effect of moisture content on flowability: angle of repose, tilting angle, and Hausner ratio. Powder Technol. 2021;393:582–96. doi: https://doi.org/10.1016/j.powtec.2021.08.010
19. Armstrong NA. Tablet manufacture by direct compression. Encyclopedia Pharmaceut Technol. 2007;6:3673–83.
20. Arndt OR, Baggio R, Adam AK, Harting J, Franceschinis E, Kleinebudde P. Impact of different dry and wet granulation techniques on granule and tablet properties: a comparative study. J Pharm Sci. 2018;107(12):3143–52. doi: https://doi.org/10.1016/j.xphs.2018.09.006
21. Munjal B, Koradia V, Boddu SH, Bansal AK. Role of innovator product characterization in generic product development. In: Ajit S Narang SHSB, editor. Excipient applications in formulation design and drug delivery. 2015. pp. 521–38. doi: https://doi.org/10.1007/978-3-319-20206-8_17
22. Helmy SA, El Bedaiwy HM. In vitro dissolution similarity as a surrogate for in vivo bioavailability and therapeutic equivalence. Dissolution Technol. 2016;23:32–9. doi: https://doi.org/10.14227/DT230316P32
23. Thi My Huynh D, Le MN, Tran QT, Dang K. Formulation and stability of orally fast disintegrating tablets of amlodipine besylate. R J Pharm Technol. 2023;16(9):4049–57. doi: https://doi.org/10.52711/0974-360X.2023.00664
24. Osei-Yeboah F, Sun CC. Validation and applications of an expedited tablet friability method. Int J Pharm. 2015;484(1):146–55. doi: https://doi.org/10.1016/j.ijpharm.2015.02.061
25. Sinka I, Motazedian F, Cocks A, Pitt K. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol. 2009;189(2):276–84. doi: https://doi.org/10.1016/j.powtec.2008.04.020
26. Lay Peng Soh J, Valeria Liew C, Wan Sia Heng P. Impact of excipient variability on drug product processing and performance. Curr Pharm Design. 2015;21(40):5890–9. doi: https://doi.org/10.2174/13816128 21666151008124932
27. Varma MV, Kaushal AM, Garg A, Garg S. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am J Drug Deliv. 2004;2:43– 57. doi: https://doi.org/10.2165/00137696-200402010-00003
28. Vellaichamy S, Soundarapandian A, Narayanan V, Kunjiappan S, Velayutham R, James A. Influence of cetyl alcohol and enteric polymers on the release of water soluble drug in monolithic bilayered matrix tablet. World J Pharm Sci. 2019;7(4):1–8.
29. Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodríguez F, Heinämäki J.Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm. 2006;317(1):32–9. doi: https://doi.org/10.1016/j.ijpharm.2006.02.049
30. Quadir MA, Rahman MS, Karim MZ, Akter S, Awkat M, Reza MS. Evaluation of hydrophobic materials as matrices for controlled-release drug delivery. Pak J Pharm Sci. 2003;16(2):17–28.
31. Guan J, Mao S. Natural polymers for pharmaceutical applications. New York, NY: Apple Academic Press; 2019. 21–48. doi: https://doi.org/10.1201/9780429328251
32. Onyechi J, Okafo S. Evaluation of carnauba wax in sustained release diclofenac sodium tablet formulation. J Chem Pharm Res. 2016;8(3):714–21.
Year
Month